S 2554 115th Congress

Patient Right to Know Drug Prices Act

Latest Action

Became Public Law No: 115-263.

Summary

Patient Right to Know Drug Prices Act (Sec. 2) This bill amends the Public Health Service Act to prohibit a health insurance plan or pharmacy benefits manager from restricting a pharmacy from informing an enrollee of any difference between the out-of-pocket cost of a drug under the plan and the cost of the drug without health insurance coverage. (Such restrictions are commonly referred to as gag clauses.) (Sec. 3) The bill also amends the Medicare Prescription Drug, Improvement, and Modernization Act of 2003 to apply certain antitrust filing requirements for generic drug applicants to biosimilar biological product applicants. (Biosimilar biological products, commonly referred to as biosimilars, are biological products approved by the Food and Drug Administration based on their similarity to an already-approved biological product.) Under current law, generic drug applicants that make agreements with brand name drug companies or other generic drug applicants regarding the manufacture, marketing, or sale of their drugs must file such agreements with the Federal Trade Commission and the Department of Justice. The bill subjects biosimilar biological product applicants to the same filing requirements.

Vote Result

Bill Passed (98-2) Senate

Passed Senate with an amendment by Yea-Nay Vote. 98 - 2. Record Vote Number: 209.

Actions

2018-10-10T00:00:00

Became Public Law No: 115-263.

2018-10-10T00:00:00

Became Public Law No: 115-263.

2018-10-10T00:00:00

Signed by President.

2018-10-10T00:00:00

Signed by President.

2018-10-01T00:00:00

Presented to President.

2018-10-01T00:00:00

Presented to President.

2018-09-25T00:00:00

Motion to reconsider laid on the table Agreed to without objection.

2018-09-25T00:00:00

On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H8795-8796)

2018-09-25T00:00:00

Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by voice vote.(text: CR H8795-8796)

2018-09-25T00:00:00

DEBATE - The House proceeded with forty minutes of debate on S. 2554.

2018-09-25T00:00:00

Considered under suspension of the rules. (consideration: CR H8795-8799)

2018-09-25T00:00:00

Mr. Carter (GA) moved to suspend the rules and pass the bill.

2018-09-20T00:00:00

Held at the desk.

2018-09-20T00:00:00

Received in the House.

2018-09-18T00:00:00

Message on Senate action sent to the House.

2018-09-17T00:00:00

Passed Senate with an amendment by Yea-Nay Vote. 98 - 2. Record Vote Number: 209.

2018-09-17T00:00:00

Passed/agreed to in Senate: Passed Senate with an amendment by Yea-Nay Vote. 98 - 2. Record Vote Number: 209.

2018-09-17T00:00:00

Measure laid before Senate by unanimous consent. (consideration: CR S6179-6180)

2018-07-31T00:00:00

Placed on Senate Legislative Calendar under General Orders. Calendar No. 549.

2018-07-31T00:00:00

Committee on Health, Education, Labor, and Pensions. Reported by Senator Alexander with an amendment in the nature of a substitute. Without written report.

2018-07-31T00:00:00

Committee on Health, Education, Labor, and Pensions. Reported by Senator Alexander with an amendment in the nature of a substitute. Without written report.

2018-07-25T00:00:00

Committee on Health, Education, Labor, and Pensions. Ordered to be reported with an amendment in the nature of a substitute favorably.

2018-03-14T00:00:00

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

2018-03-14T00:00:00

Introduced in Senate

Policy Areas

Health

Track this bill on CivicBeacon

Get push notifications when this bill is updated, contact your reps, and take action.

Patient Right to Know Drug Prices Act

Sponsors

Summary

Vote Result

Actions

Policy Areas

Track this bill on CivicBeacon